Results 111 to 120 of about 2,559,828 (152)

Integrative microRNA and mRNA expression profiling in acute aristolochic acid nephropathy in mice. [PDF]

Mol Med Rep, 2020
Zhu Z, Xu X, Wang F, Song Y, Zhu Y, Quan W, Zhang X, Bi C, He H, Li S, Li X.   +10 more
europepmc   +1 more source

Blockade of the mTOR signaling pathway with rapamycin ameliorates aristolochic acid nephropathy. [PDF]

Exp Ther Med, 2020
Wu M, Tang L, Chen B, Zheng J, Dong F, Su Z, Lin F.   +6 more
europepmc   +1 more source

Renoprotective effect of <i>Stat1</i> deletion in murine aristolochic acid nephropathy.

Am J Physiol Renal Physiol, 2021
Feng W, Ying WZ, Li X, Curtis LM, Sanders PW.   +4 more
europepmc   +1 more source

The transcription factor Twist1 in the distal nephron but not in macrophages propagates aristolochic acid nephropathy. [PDF]

Kidney Int, 2020
Ren J, Rudemiller NP, Wen Y, Lu X, Privratsky JR, Crowley SD.   +5 more
europepmc   +1 more source

Molecular pathogenesis of aristolochic acid-induced urothelial carcinoma in a belgian cohort after accidental exposure during weight loss regimen

, 2018
In the early nineties, about 100 young women who were dieting in the same clinic developed rapidly progressive renal failure within a few months, further complicated by the occurrence of urothelial carcinoma of the upper urinary tract.
Aydin, Selda
core  

ZBP1 promotes RIPK1-dependent apoptosis in aristolochic acid nephropathy. [PDF]

Zool Res
Zou Z, Ye K, Chen F, Lin K, Song Y, Li G, Chen C, Wang Y, Ma H, Xu Y.   +9 more
europepmc   +1 more source

Deletion of decay-accelerating factor in kidney tubular cells mitigates kidney fibrosis in aristolochic acid nephropathy. [PDF]

Am J Physiol Renal Physiol
Yu SM, King E, Khleif S, Cravedi P.
europepmc   +1 more source

Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma complicated with aristolochic acid nephropathy after radical nephroureterectomy. [PDF]

BMC Complement Med Ther, 2020
Shan H, Tian W, Hong Y, Xu B, Wang C, Yu B, Wang X.   +6 more
europepmc   +1 more source

Inhibition of MCL-1 to eliminate senescent cells and mitigate renal fibrosis in aristolochic acid nephropathy. [PDF]

Cell Death Dis
Gao P, Cenatus S, Henley N, Pichette V, Mallette FA, Barrera-Chimal J, Gerarduzzi C.   +6 more
europepmc   +1 more source

Enhancement of angiotensin II type 1 receptor-associated protein suppresses kidney inflammation in a mouse model of aristolochic acid nephropathy. [PDF]

Sci Rep
Furuta R, Urate S, Wakui H, Uehara T, Tsukamoto S, Taguchi S, Morita R, Okami N, Yamashita A, Azushima K, Tamura K.   +10 more
europepmc   +1 more source